Health Canada Licenses the Device. The Class Decides the Evidence.
Medical Device Licence strategy under the Canadian Medical Devices Regulations — the Class II, III, or IV application, built on the MDSAP certificate it rests on, and kept live through annual renewal.
Classification Sets Everything — Including Whether You Need a Licence at All.
Health Canada classifies devices I through IV by risk. Class I devices don’t get a device licence — they ride an establishment licence. Classes II, III, and IV each need an MDL, and the evidence climbs with the class.
No Device Licence
The lowest-risk devices — non-invasive, low consequence. They are licensed at the company level, not the product level.
Attestation-Based Licence
Lower-risk devices whose licence rests largely on the manufacturer’s attestations of safety and effectiveness, plus the QMS certificate.
Evidence-Backed Licence
Higher-risk devices requiring a summary of the safety and effectiveness evidence, risk assessment, and often clinical data to support the claims.
Full Evidence Licence
The highest-risk devices — life-sustaining, implantable, high consequence. The most demanding evidence package Health Canada reviews.
The MDSAP certificate is not optional. A Class II, III, or IV licence rests on a valid Medical Device Single Audit Program certificate — in Canada, MDSAP is the price of the licence, not a nice-to-have.
A US Clearance Doesn’t Cross the Border. The File Has to Be Rebuilt for Canada.
Health Canada runs its own classification rules, its own evidence expectations, and its own licence under the Medical Devices Regulations (SOR/98-282). A device that is Class II at FDA can land in a different class here, and the licence application is a Canadian document — not a re-stapled 510(k).
What US teams underestimate most is the MDSAP dependency and the annual renewal. The licence is granted against a current MDSAP certificate and must be renewed every year before the deadline — miss it and the licence lapses, and with it your legal ability to sell.
Classification, evidence, and licensing all follow Canadian rules — the US dossier is a starting point, not a shortcut.
Six Disciplines That Carry an MDL.
From the classification call to the renewal calendar that keeps the licence from quietly lapsing.
Canadian Classification
The Health Canada class determined under the Canadian rules — because Class II, III, and IV are three different applications, and Class I isn’t an MDL at all.
MDSAP-Linked Strategy
The licence application sequenced against a valid MDSAP certificate — the two are joined, and filing without the certificate in hand stalls the review.
MDL Application Build
The application assembled to the class: attestations for Class II, safety-and-effectiveness summaries and risk evidence for III and IV, organised the way the Medical Devices Bureau reads it.
Evidence & Labelling Package
The clinical, risk, and labelling evidence sized to the class — and the Canadian labelling and bilingual requirements that trip up US-built files.
Annual Licence Renewal
The yearly renewal owned and filed before the deadline — the unglamorous obligation that, missed, cancels a licence you spent months earning.
Licence Amendments
Significant changes filed as licence amendments before they ship — so the device on the market always matches the device on the licence.
Canada makes MDSAP the price of entry — and that same certificate opens four more markets.
Canada Was the Country That Made MDSAP Mandatory. Use That.
Canada is the only MDSAP participating regulator that requires the certificate for market access — which means most companies encounter MDSAP because Canada forces the question. Handled well, the same audit that unlocks Canada also serves the US, Australia, Japan, and Brazil.
We build the licence strategy and the MDSAP certification together, so the audit and the application reinforce each other instead of colliding — and so one quality system carries you into five markets, not one.
Six Failure Modes We Are Brought In to Prevent.
Most are a US team assuming Canada works like FDA — it doesn’t.
The MDSAP afterthought
Filing the MDL before the MDSAP certificate is in hand — and stalling the review until the audit that should have come first is complete.
Wrong-class assumption
Assuming the FDA class carries to Canada — and building the wrong evidence package for a device Health Canada classifies a tier higher.
The missed renewal
The annual renewal deadline missed because nobody owned it — and a cancelled licence discovered when an order can’t ship.
Labelling that isn’t Canadian
US labelling submitted without the Canadian and bilingual requirements — a deficiency that sends the file back.
Changes that outran the licence
Significant device changes shipped without a licence amendment — the Canadian version of the letter-to-file gap.
Treating Canada as an afterthought
The Canadian file started last, under launch pressure — when its MDSAP dependency makes it the one that needs the longest runway.
Canadian Market Access, Run by People Who Know Its Rules.
Our leads have taken Class II through IV devices through Health Canada, coordinated MDSAP audits, and kept licences current through renewal.
“Canada punishes the assumption that it’s a smaller United States. Different classes, a mandatory audit, and a renewal clock — respect those three and it’s a clean market.”
The discipline we bring to Canadian licensing.
Taking a Device Into Canada? Start With the Class and the Certificate.
A senior lead can settle your Health Canada class, sequence the MDSAP audit, and map the licence and renewal before the launch date sets the schedule for you.
Senior-led. Embedded in your team. No junior hand-offs.